Apuli Maricel - Insider Non-Derivative Transactions at BridgeBio Pharma, Inc. (BBIO) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 12, 2025, Apuli Maricel's relationship to BridgeBio Pharma, Inc. (BBIO) is Officer (Chief Accounting Officer), and currently has 128,294 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BBIO insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Apuli Maricel - Insider Non-Derivative Transactions of BBIO Common Stock

Apuli Maricel - Insider Non-Derivative Transactions at BBIO

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 13, 2025	F -- (Common Stock)	2003	75.15	128294
Dec 9, 2025	Sell -- (Common Stock)	2000	74.26	130297
Nov 17, 2025	F -- (Common Stock)	4781	66.39	132297
Aug 17, 2025	F -- (Common Stock)	4781	51.32	137078
Aug 8, 2025	Sell -- (Common Stock)	1000	45.44	141859
May 17, 2025	F -- (Common Stock)	4780	33.84	142859
May 3, 2025	Sell -- (Common Stock)	1026	38.51	147639
Mar 20, 2025	Acquisition -- (Common Stock)	23660	0	148665